Production of EGF-collagen chimeric protein which shows the mitogenic activity

被引:17
作者
Hayashi, M
Tomita, M
Yoshizato, K
机构
[1] Hiroshima Univ, Dev Biol Lab, Dept Biol Sci, Grad Sch Sci, Hiroshima 7398526, Japan
[2] Japan Sci & Technol Corp, Hiroshima Tissue Regenerat Project, Hiroshima Prefecture Collaborat Reg Ent Advanceme, Hiroshima Prefecture Inst Ind Sci & Technol, Hiroshima 7390046, Japan
[3] Terumo Co Ltd, Ctr Res & Dev, Nakai, Kanagawa 2590151, Japan
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS | 2001年 / 1528卷 / 2-3期
关键词
recombinant protein; fusion protein; type III collagen; biomaterial; growth factor;
D O I
10.1016/S0304-4165(01)00187-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Collagen has been utilized as a natural biomaterial because of its high biocompatibility, adhesiveness to cells and tissues, and biodegradability. The present study developed a recombinant technology to confer a mitogenic activity on type III collagen by fusing it to epidermal growth factor (EGF) at the collagen's N-terminus. The chimeric protein of EGF-collagen was synthesized in insect cells by the baculovirus-insect cell expression system. The fusion protein was shown to hold the triple helical conformation of collagen and the mitogenic activity of EGF. It was also demonstrated that the chimeric protein can be immobilized on tissue culture dishes as a fibrous form and in collagen fibrils without abolishing the original mitogenic, activity of EGF. This fusion protein can be utilized as a biocompatible, biodegradable, and adhesive fibrous mitogen for a variety of purposes in the area of tissue engineering. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:187 / 195
页数:9
相关论文
共 53 条
[1]  
ADAMS JC, 1993, DEVELOPMENT, V117, P1183
[2]   STRUCTURE OF CDNA CLONES CODING FOR THE ENTIRE PREPRO-ALPHA-1(III) CHAIN OF HUMAN TYPE-III PROCOLLAGEN - DIFFERENCES IN PROTEIN-STRUCTURE FROM TYPE-I PROCOLLAGEN AND CONSERVATION OF CODON PREFERENCES [J].
ALAKOKKO, L ;
KONTUSAARI, S ;
BALDWIN, CT ;
KUIVANIEMI, H ;
PROCKOP, DJ .
BIOCHEMICAL JOURNAL, 1989, 260 (02) :509-516
[3]   Cloning of the human prolyl 4-hydroxylase alpha subunit isoform alpha(II) and characterization of the type II enzyme tetramer - The alpha(I) and alpha(II) subunits do not form a mixed alpha(I)alpha(II)beta(2) tetramer [J].
Annunen, P ;
Helaakoski, T ;
Myllyharju, J ;
Veijola, J ;
Pihlajaniemi, T ;
Kivirikko, KI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (28) :17342-17348
[4]   EPIDERMAL GROWTH-FACTOR IN THE HEALING OF CORNEAL WOUNDS, EPIDERMAL WOUNDS AND PARTIAL-THICKNESS SCALDS - A CONTROLLED ANIMAL STUDY [J].
ARTURSON, G .
SCANDINAVIAN JOURNAL OF PLASTIC AND RECONSTRUCTIVE SURGERY AND HAND SURGERY, 1984, 18 (01) :33-37
[5]  
Asahina K, 1999, DEV DYNAM, V216, P59, DOI 10.1002/(SICI)1097-0177(199909)216:1<59::AID-DVDY8>3.0.CO
[6]  
2-B
[7]   The fate of collagen implants in tissue defects [J].
Bailey, AJ .
WOUND REPAIR AND REGENERATION, 2000, 8 (01) :5-12
[8]   GROWTH-FACTORS AND WOUND-HEALING .2. ROLE IN NORMAL AND CHRONIC WOUND-HEALING [J].
BENNETT, NT ;
SCHULTZ, GS .
AMERICAN JOURNAL OF SURGERY, 1993, 166 (01) :74-81
[9]   STIMULATION OF HEALING OF CHRONIC WOUNDS BY EPIDERMAL GROWTH-FACTOR [J].
BROWN, GL ;
CURTSINGER, L ;
JURKIEWICZ, MJ ;
NAHAI, F ;
SCHULTZ, G .
PLASTIC AND RECONSTRUCTIVE SURGERY, 1991, 88 (02) :189-194
[10]  
BROWN GL, 1986, J EXP MED, V163, P1319